This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hanabuchi, S.
Right arrow Articles by Kannagi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanabuchi, S.
Right arrow Articles by Kannagi, M.

 Previous Article  |  Next Article 

Journal of Virology, January 2000, p. 428-435, Vol. 74, No. 1
0022-538X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Development of Human T-Cell Leukemia Virus Type 1-Transformed Tumors in Rats following Suppression of T-Cell Immunity by CD80 and CD86 Blockade

Shino Hanabuchi,1 Takashi Ohashi,1 Yoshihiro Koya,1 Hirotomo Kato,1,2 Fumiyo Takemura,1,3 Katsuiku Hirokawa,4 Takashi Yoshiki,5 Hideo Yagita,3,6 Ko Okumura,3,6 and Mari Kannagi1,3,*

Departments of Immunotherapeutics1 and Pathology and Immunology,4 Tokyo Medical and Dental University, Medical Research Division, Department of Veterinary Internal Medicine, Faculty of Agriculture, University of Tokyo,2 and Department of Immunology, Juntendo University School of Medicine,6 Tokyo 113, CREST, Japan Science and Technology Corporation, Saitama 332,3 and Department of Pathology, Hokkaido University School of Medicine, Sapporo 060,5 Japan

Received 14 April 1999/Accepted 21 September 1999

Host immunity influences clinical manifestations of human T-cell leukemia virus type 1 (HTLV-1) infection. In this study, we demonstrated that HTLV-1-transformed tumors could develop in immunocompetent rats by blocking a costimulatory signal for T-cell immune responses. Four-week-old WKA/HKm rats were treated with monoclonal antibodies (MAbs) to CD80 and CD86 and subcutaneously inoculated with syngeneic HTLV-1-infected TARS-1 cells. During MAb treatment for 14 days, TARS-1 inoculation resulted in the development of solid tumors at the site of inoculation, which metastasized to the lungs. In contrast, rats not treated with MAbs promptly rejected tumor cells. Splenic T cells from MAb-treated rats indicated impairment of proliferative and cytotoxic T-lymphocyte responses against TARS-1 in vitro compared to untreated rats. However, tumors grown in MAb-treated rats regressed following withdrawal of MAb therapy. Recovery of TARS-1-specific T-cell immune responses was associated with tumor regression in these rats. Our results suggest that HTLV-1-specific cell-mediated immunity plays a critical role in immunosurveillance against HTLV-1-transformed tumor development in vivo.


* Corresponding author. Mailing address: Department of Immunotherapeutics, Tokyo Medical and Dental University, Medical Research Division, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113, Japan. Phone: 81 (3) 5803-5798. Fax: 81 (3) 5803-0235. E-mail: kann.impt{at}med.tmd.ac.jp.


Journal of Virology, January 2000, p. 428-435, Vol. 74, No. 1
0022-538X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Nomura, M., Ohashi, T., Nishikawa, K., Nishitsuji, H., Kurihara, K., Hasegawa, A., Furuta, R. A., Fujisawa, J.-i., Tanaka, Y., Hanabuchi, S., Harashima, N., Masuda, T., Kannagi, M. (2004). Repression of Tax Expression Is Associated both with Resistance of Human T-Cell Leukemia Virus Type 1-Infected T Cells to Killing by Tax-Specific Cytotoxic T Lymphocytes and with Impaired Tumorigenicity in a Rat Model. J. Virol. 78: 3827-3836 [Abstract] [Full Text]  
  • Harashima, N., Kurihara, K., Utsunomiya, A., Tanosaki, R., Hanabuchi, S., Masuda, M., Ohashi, T., Fukui, F., Hasegawa, A., Masuda, T., Takaue, Y., Okamura, J., Kannagi, M. (2004). Graft-versus-Tax Response in Adult T-Cell Leukemia Patients after Hematopoietic Stem Cell Transplantation. Cancer Res. 64: 391-399 [Abstract] [Full Text]  
  • Hasegawa, A., Ohashi, T., Hanabuchi, S., Kato, H., Takemura, F., Masuda, T., Kannagi, M. (2003). Expansion of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Reservoir in Orally Infected Rats: Inverse Correlation with HTLV-1-Specific Cellular Immune Response. J. Virol. 77: 2956-2963 [Abstract] [Full Text]  
  • Ohashi, T., Hanabuchi, S., Suzuki, R., Kato, H., Masuda, T., Kannagi, M. (2002). Correlation of Major Histocompatibility Complex Class I Downregulation with Resistance of Human T-Cell Leukemia Virus Type 1-Infected T Cells to Cytotoxic T-Lymphocyte Killing in a Rat Model. J. Virol. 76: 7010-7019 [Abstract] [Full Text]  
  • Hanabuchi, S., Ohashi, T., Koya, Y., Kato, H., Hasegawa, A., Takemura, F., Masuda, T., Kannagi, M. (2001). Regression of Human T-cell Leukemia Virus Type I (HTLV-I)-Associated Lymphomas in a Rat Model: Peptide-Induced T-Cell Immunity. JNCI J Natl Cancer Inst 93: 1775-1783 [Abstract] [Full Text]  
  • Mortreux, F., Leclercq, I., Gabet, A.-S., Leroy, A., Westhof, E., Gessain, A., Wain-Hobson, S., Wattel, E. (2001). Somatic Mutation in Human T-Cell Leukemia Virus Type 1 Provirus and Flanking Cellular Sequences During Clonal Expansion In Vivo. JNCI J Natl Cancer Inst 93: 367-377 [Abstract] [Full Text]  
  • Mortreux, F., Kazanji, M., Gabet, A.-S., de Thoisy, B., Wattel, E. (2001). Two-Step Nature of Human T-Cell Leukemia Virus Type 1 Replication in Experimentally Infected Squirrel Monkeys (Saimiri sciureus). J. Virol. 75: 1083-1089 [Abstract] [Full Text]  
  • Ohashi, T., Hanabuchi, S., Kato, H., Tateno, H., Takemura, F., Tsukahara, T., Koya, Y., Hasegawa, A., Masuda, T., Kannagi, M. (2000). Prevention of Adult T-Cell Leukemia-Like Lymphoproliferative Disease in Rats by Adoptively Transferred T Cells from a Donor Immunized with Human T-Cell Leukemia Virus Type 1 Tax-Coding DNA Vaccine. J. Virol. 74: 9610-9616 [Abstract] [Full Text]